Home/Filings/4/0001144204-13-055677
4//SEC Filing

INTERCEPT PHARMACEUTICALS INC 4

Accession 0001144204-13-055677

CIK 0001270073operating

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 9:31 PM ET

Size

5.4 KB

Accession

0001144204-13-055677

Insider Transaction Report

Form 4
Period: 2013-10-15
Transactions
  • Sale

    Common Stock, par value $0.001 per share

    2013-10-15$62.50/sh1,123,415$70,213,4386,063,802 total(indirect: See Footnote)
Footnotes (2)
  • [F1]These shares are held by Genextra S.p.A. Mr. Micheli is the Executive Director of Genextra S.p.A. and, in such capacity, Mr. Micheli exercises voting control over the shares of common stock owned by Genextra S.p.A and investment control over such shares as authorized by the board of directors of Genextra S.p.A. Mr. Micheli disclaims beneficial ownership with respect to any such shares, except to the extent of his pecuniary interest therein, if any.
  • [F2]Represents shares of common stock sold by Genextra S.p.A. in a secondary offering pursuant to a registration statement on Form S-1 (File No. 333-191501) that was completed on October 15, 2013.

Issuer

INTERCEPT PHARMACEUTICALS INC

CIK 0001270073

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001270073

Filing Metadata

Form type
4
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 9:31 PM ET
Size
5.4 KB